MedTrace Logo

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

NCT07154823 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2026-03-03

No results posted yet for this study

Summary

The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.

Conditions

  • Acute Myeloid Leukaemia (AML)
  • Follicular Lymphoma ( FL)

Interventions

OTHER

None - Observational Study

There are no interventions in this observational study.

Sponsors & Collaborators

Principal Investigators

  • Michael Thompson, MD, PhD, FASCO · Tempus AI

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-27
Primary Completion
2034-11-30
Completion
2035-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07154823 on ClinicalTrials.gov